Drug firms hype disease as sales ploy, industry chief claims

A senior pharmaceutical company executive says estimates of the prevalence of diseases are often exaggerated.

Using the example of his company's promotion of “social phobia,” Fred Nadjarian, managing director of Roche in Australia, said: “The marketing people always beat [hype] these things up. It's just natural enthusiasm.”